View the Latest: Prescription Drugs
Filter
-
-
The Financing of Pharmacy Plus Waivers: Implications for Seniors on Medicaid of Global Funding Caps
Issue BriefThis policy brief describes Pharmacy Plus waivers being considered by some states for their Medicaid program and their implications for Medicaid financing.
-
Medicare and Prescription Drugs, Fact Sheet
Fact SheetThis fact sheet, updated in April 2003, profiles current sources of prescription drug coverage among the Medicare population, describes the characteristics of beneficiaries who lack drug coverage and the implications of being without such coverage, and provides current data on prescription drug use and spending. Fact Sheet (.
-
Prior Authorization for Medicaid Prescription Drugs in Five States: Lessons for Policy Makers
ReportThis report is a case study of five states' (California, Georgia, Oklahoma, Oregon, and Washington) implementation of prior authorization in their Medicaid programs.
-
Model Prescription Drug Prior Authorization Process for State Medicaid Programs
ReportThis report details the rules governing prior authorization programs and the major steps in a model process based on key issues raised by beneficiary advocates, provider groups and states.
-
How Do M+C Plans Manage Pharmacy Benefits? Implications for Medicare Reform
ReportUnderstanding how Medicare+Choice (M+C) plans manage their drug benefits may generate important lessons for Medicare. This report, based on interviews with both national and regional managed care firms, provides an in-depth look at how plans have managed their M+C outpatient pharmacy benefits in recent years.
-
The Development of Direct-to-Consumer Prescription Drug Advertising Regulation
Other PostThis article, which appears in the Food and Drug Law Journal, vol. 57, no. 3, 2002, pp. 423-444 was based on a report written by F.B. Palumbo and C.D. Mullins at the University of Maryland School of Pharmacy Center on Drugs and Public Policy and funded by the Kaiser Family Foundation.
-
Issue Brief: Trends in Opportunistic Infection Drug Coverage and Spending by AIDS Drug Assistance Programs
Issue BriefThis issue brief, prepared as part of the National ADAP Monitoring Project, examines ADAP formulary coverage of medications for the prevention and treatment of AIDS-related Opportunistic Infections across states, including trends in coverage and expenditures over time, and discusses some of the potential reasons for variations in coverage.
-
New Reports Explore State Implementation of Prescription Drug Prior Authorization
Other PostStates are grappling with a fiscal crisis that threatens funding for Medicaid, the federal-state partnership that provides health coverage for low-income populations. Two new studies shed light on the impact of an increasingly popular strategy - prior authorization - being used to control prescription drug spending.
-
Case Study: Michigan’s Medicaid Prescription Drug Benefit
ReportCase Study: Michigan's Medicaid Prescription Drug Benefit This report describes the legislative process behind and content of Michigan's Pharmaceutical Product List (MPPL), a selection of preferred drugs available to be prescribed in the Medicaid program with little restriction.